Side specific differences of tumor budding on non-metastatic colon cancer
dc.contributor.author | Sogutcu, N. | |
dc.contributor.author | Gumus, S. | |
dc.contributor.author | Balkan, A. Z. Abidin | |
dc.contributor.author | Bilge, H. | |
dc.contributor.author | Cakabay, B. | |
dc.date.accessioned | 2024-04-24T17:47:34Z | |
dc.date.available | 2024-04-24T17:47:34Z | |
dc.date.issued | 2022 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | OBJECTIVE: Recent literature suggests that tumor budding (TB) may have a significant clinical impact on colorectal cancers. Our study aims to reveal the effect of TB on the long-term outcomes of patients and to reveal whether there is a difference in tumor location and TB in colonic cancer. PATIENTS AND METHODS: A cohort of 100 patients with non-metastatic colon cancer was included in the study. The clinicopathological information of the patients was reviewed. Patients' preparations were reevaluated to identify TB as: low, medium, and high and represent 0-4 buds, 5-9 buds, and 10 or more buds per 0.785 mm2, respectively. Long-term oncological outcomes of patients were analyzed. The recurrence, metastasis, and final status of the patients were deter-mined during the follow-up period. RESULTS: Low TN was associated with < 65 year (p = 0.048), absence of lymphatic metastasis (p = 0.003), and absence of perineural invasion (p = 0.023). High TB was associated with higher pT stage (p = 0.017) and tumor stage (p = 0.005). Additionally, right-sided tumors had a high TB score than left side (82.3% vs. 23.6%, p = 0.011). Patients with high TB had lower overall survival, but these were not statically significant. According to multiple regression analysis, mortality risk was associated with age (p = 0.046), pN status (p = 0.003) and TB (p = 0.040). CONCLUSIONS: High TB is associated with mortality in colon cancer and is more common in right colonic carcinoma. | en_US |
dc.identifier.endpage | 7655 | en_US |
dc.identifier.issn | 1128-3602 | |
dc.identifier.issue | 20 | en_US |
dc.identifier.pmid | 36314336 | |
dc.identifier.startpage | 7649 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/22604 | |
dc.identifier.volume | 26 | en_US |
dc.identifier.wos | WOS:000883538600011 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | Verduci Publisher | en_US |
dc.relation.ispartof | European Review For Medical and Pharmacological Sciences | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Colon Cancer | en_US |
dc.subject | Cancer Localization | en_US |
dc.subject | Tumor Budding | en_US |
dc.title | Side specific differences of tumor budding on non-metastatic colon cancer | en_US |
dc.title | Side specific differences of tumor budding on non-metastatic colon cancer | |
dc.type | Article | en_US |